SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    JSH Guidelines for the Management of Hepatitis B Virus Infection, Hepatology Research, 2014, 44,
  2. 2
    Makoto Oketani, Hirofumi Uto, Akio Ido, Hirohito Tsubouchi, Management of hepatitis B virus-related acute liver failure, Clinical Journal of Gastroenterology, 2014, 7, 1, 19

    CrossRef

  3. 3
    J. Wiegand, H. Wedemeyer, A. Franke, S. Rößler, S. Zeuzem, G. Teuber, M. Wächtler, U. Römmele, B. Ruf, U. Spengler, C. Trautwein, C. T. Bock, G. M. Fiedler, J. Thiery, M. P. Manns, O. Brosteanu, H. L. Tillmann, Treatment of severe, nonfulminant acute hepatitis B with lamivudine vs placebo: a prospective randomized double-blinded multicentre trial, Journal of Viral Hepatitis, 2014, 21, 5
  4. 4
    Chris Willars, Update in intensive care medicine, Current Opinion in Critical Care, 2014, 20, 2, 202

    CrossRef

  5. 5
    P. Manka, C. Jochum, J. Timm, A. Canbay, Akute Virushepatitis und Leberversagen, Der Gastroenterologe, 2013, 8, 1, 7

    CrossRef

  6. 6
    Luwen Wang, Hui Chen, Cheng Fan, Zuojiong Gong, Efficacy and safety of telbivudine therapy in liver failure patients with chronic hepatitis B virus infection, Journal of Medical Virology, 2013, 85, 11
  7. 7
    Marc A. Suchard, Ivan Zorych, Shawn E. Simpson, Martijn J. Schuemie, Patrick B. Ryan, David Madigan, Empirical Performance of the Self-Controlled Case Series Design: Lessons for Developing a Risk Identification and Analysis System, Drug Safety, 2013, 36, S1, 83

    CrossRef

  8. 8
    Bingliang Lin, Calvin Q. Pan, Dongying Xie, Junqiang Xie, Shibin Xie, Xiaohong Zhang, Biao Wu, Chaoshuang Lin, Zhiliang Gao, Entecavir improves the outcome of acute-on-chronic liver failure due to the acute exacerbation of chronic hepatitis B, Hepatology International, 2013, 7, 2, 460

    CrossRef

  9. You have free access to this content9
    Robert P. Perrillo, Hepatitis B virus treatment: Which patients require immediate treatment, Clinical Liver Disease, 2013, 2, 1
  10. You have free access to this content10
    Ankur Jindal, Manoj Kumar, Shiv K. Sarin, Management of acute hepatitis B and reactivation of hepatitis B, Liver International, 2013, 33,
  11. 11
    Etienne M. Sokal, Massimiliano Paganelli, Stefan Wirth, Piotr Socha, Pietro Vajro, Florence Lacaille, Deirdre Kelly, Giorgina Mieli-Vergani, Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines, Journal of Hepatology, 2013, 59, 4, 814

    CrossRef

  12. 12
    Filippo Morando, Silvia Rosi, Silvano Fasolato, Marta Cavallin, Elisabetta Gola, Angelo Gatta, Paolo Angeli, Severe acute hepatitis B in a treatment-naïve patient with antiviral drug resistant mutations in the polymerase gene, Journal of Medical Virology, 2013, 85, 2
  13. You have free access to this content13
    Robert P. Perrillo, Tratamiento del virus de la hepatitis B: ¿qué pacientes deben recibir tratamiento inmediato?, Clinical Liver Disease, 2013, 2, S5
  14. 14
    Pierre Van Damme, John Ward, Daniel Shouval, Steven Wiersma, Alessandro Zanetti, Vaccines, 2013,

    CrossRef

  15. 15
    Catherine Paugam-Burtz, Emmanuel Weiss, Richard Moreau, Critical Care in Acute Liver Failure, 2013,

    CrossRef

  16. 16
    Chunchen Wu, Hui Shi, Yun Wang, Mengji Lu, Yang Xu, Xinwen Chen, A case of hepatitis B reactivation due to the hepatitis B virus escape mutant in a patient undergoing chemotherapy, Virologica Sinica, 2012, 27, 6, 368

    CrossRef

  17. 17
    Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen, Acute-on-chronic liver failure in chronic hepatitis B, Journal of Gastroenterology and Hepatology, 2012, 27, 4
  18. 18
    Katharina Staufer, Michael Trauner, Valentin Fuhrmann, Akutes Leberversagen, Wiener klinische Wochenschrift Education, 2012, 7, 2, 59

    CrossRef

  19. 19
    J. Hadem, K. Rifai, Akutes Leberversagen, Der Gastroenterologe, 2012, 7, 2, 87

    CrossRef

  20. 20
    Ke Ma, Wei Guo, Meifang Han, Guang Chen, Tao Chen, Zenguang Wu, Daofeng Yang, Jiaquan Huang, Yuancheng Huang, Xiping Zhao, Deying Tian, Jianxin Song, Junying Qi, Qin Ning, Entecavir treatment prevents disease progression in hepatitis B virus-related acute-on-chronic liver failure: establishment of a novel logistical regression model, Hepatology International, 2012, 6, 4, 735

    CrossRef

  21. 21
    KASL Clinical Practice Guidelines: Management of chronic hepatitis B, Clinical and Molecular Hepatology, 2012, 18, 2, 109

    CrossRef

  22. 22
    F. Casals-Seoane, B. Arberas-Diez, R. Moreno-Otero, Letter: acute hepatitis B – to treat or not to treat?, Alimentary Pharmacology & Therapeutics, 2012, 36, 1
  23. 23
    Hans L. Tillmann, Kalliopi Zachou, George N. Dalekos, Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?, Liver International, 2012, 32, 4
  24. 24
    Xing Li, Yan-Fang Xing, Qu Lin, Min Dong, Xiang-Bo Wan, Xiang-Yuan Wu, The treatment of severe hepatitis B virus reactivation after chemotherapy, Nature Reviews Clinical Oncology, 2012, 9, 6, 350

    CrossRef

  25. 25
    Francisco Javier García-Alonso, Rosa María Martín-Mateos, Víctor Moreira Vicente, Tratamiento farmacológico de la hepatitis B aguda, Medicina Clínica, 2012, 138, 14, 633

    CrossRef

  26. 26
    Doan Y. Dao, Emmanuel Seremba, Veeral Ajmera, Corron Sanders, Linda S. Hynan, William M. Lee, Use of Nucleoside (Tide) Analogues in Patients with Hepatitis B-Related Acute Liver Failure, Digestive Diseases and Sciences, 2012, 57, 5, 1349

    CrossRef

  27. 27
    Heiner Wedemeyer, Jean-Michel Pawlotsky, Goldman's Cecil Medicine, 2012,

    CrossRef

  28. 28
    Akahito Sako, Hideo Yasunaga, Hiromasa Horiguchi, Hideki Hashimoto, Naohiko Masaki, Shinya Matsuda, Acute hepatitis B in Japan: Incidence, clinical practices and health policy, Hepatology Research, 2011, 41, 1
  29. 29
    J. Hadem, A.S. Schneider, M.P. Manns, Akutes Leberversagen, Der Internist, 2011, 52, 7, 804

    CrossRef

  30. 30
    Jian-Wu Yu, Li-Jie Sun, Bing-Zhu Yan, Peng Kang, Yong-Hua Zhao, Lamivudine treatment is associated with improved survival in fulminant hepatitis B, Liver International, 2011, 31, 4
  31. 31
    Irene N Rapti, Stephanos J Hadziyannis, Treatment of special populations with chronic hepatitis B infection, Expert Review of Gastroenterology & Hepatology, 2011, 5, 3, 323

    CrossRef

  32. 32
    Markus Peck-Radosavljevic, Johann Deutsch, Peter Ferenci, Ivo Graziadei, Harald Hofer, Heidemarie Holzmann, Wolf-Dietrich Huber, Herman Laferl, Andreas Maieron, Rudolf Stauber, Wolfgang Vogel, 4. Österreichischer Konsensusbericht zur Diagnose und Therapie der Hepatitis B 2009, Wiener klinische Wochenschrift, 2010, 122, 9-10, 280

    CrossRef

  33. 33
    William Bernal, Georg Auzinger, Anil Dhawan, Julia Wendon, Acute liver failure, The Lancet, 2010, 376, 9736, 190

    CrossRef

  34. 34
    Tenita P. Foston, David Carpentar, Acute Liver Failure, Critical Care Nursing Clinics of North America, 2010, 22, 3, 395

    CrossRef

  35. 35
    Henry Lik-Yuen Chan, Antiviral Therapy for Acute-on-Chronic Liver Failure in Chronic Hepatitis B: Is It Too Late?, Digestive Diseases and Sciences, 2010, 55, 8, 2126

    CrossRef

  36. 36
    Michelle Lai, Yun-Fan Liaw, Chronic Hepatitis B: Past, Present, and Future, Clinics in Liver Disease, 2010, 14, 3, 531

    CrossRef

  37. You have free access to this content37
    Li-Jie Sun, Jian-Wu Yu, Yong-Hua Zhao, Peng Kang, Shu-Chen Li, Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure, Journal of Gastroenterology and Hepatology, 2010, 25, 3
  38. 38
    Vidyut Bhatia, Rakesh Lodha, Intensive Care Management of Children with Acute Liver Failure, The Indian Journa